SodaStream (SODA) had Strong Holiday Season, Thinks Oppenheimer
Tweet
Share
E-mailGet Alerts SODA Hot Sheet
Price: $143.68 --0%
Rating Summary:
3 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
3 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Today analysts at Oppenheimer reiterated their bullish call on home beverage company SodaStream (Nasdaq: SODA). Following discussions with SODA executive Yonah Lloyd, analysts said they think profitability is reaching an inflection point. They are also optimistic about increased advertising.
"As expected, Mr. Lloyd noted that SODA had an excellent 4Q worldwide and a very strong holiday season in the US, helped by a new television advertising campaign and the launch of the Source machine," said analyst Joseph Altobello.
Altobello expects momentum at SodaStream to continue to build in 2013 and reiterating an Outperform rating on the stock, with a upward revised price target of $60 (from $55).
For an analyst ratings summary and ratings history on SodaStream International (Nasdaq: SODA) click here. For more ratings news on SodaStream International click here.
Shares of SodaStream International closed at $49.75 yesterday.
"As expected, Mr. Lloyd noted that SODA had an excellent 4Q worldwide and a very strong holiday season in the US, helped by a new television advertising campaign and the launch of the Source machine," said analyst Joseph Altobello.
Altobello expects momentum at SodaStream to continue to build in 2013 and reiterating an Outperform rating on the stock, with a upward revised price target of $60 (from $55).
For an analyst ratings summary and ratings history on SodaStream International (Nasdaq: SODA) click here. For more ratings news on SodaStream International click here.
Shares of SodaStream International closed at $49.75 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keurig Dr Pepper (KDP) PT Raised to $39 at Jefferies
- Sage Therapeutics (SAGE) PT Lowered to $18 at Truist Securities
- Merck (MRK) PT Raised to $143 at Truist Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
